home / stock / gild / gild articles

GILD Articles, Gilead Sciences Inc. - From 01/22/24

Stock Information
Company Name: Gilead Sciences Inc.
Stock Symbol: GILD
Market: NASDAQ
Website: gilead.com
Menu
GILD GILD Quote GILD Short GILD News GILD Articles GILD Message Board
Get GILD Alerts

News, Short Squeeze, Breakout and More Instantly...
Crude Oil Surges Over 2%; US Leading Economic Index Falls In December | Benzinga

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 150 points on Monday. The Dow traded up 0.41% to 38,018.2...
Why Is HIV Drug Giant Gilead Stock Falling Monday? | Benzinga

Gilead Sciences Inc (NASDAQ:GILD) said its Phase 3 EVOKE-01 study did not meet its primary endpoint of overall survival (OS) in previously tre...

EXCLUSIVE: The 'Buy Everything' Market Is Over: Synopsys-Ansys Merger Provides Fertile Ground For This Stock Picker | Benzinga

The Federal Reserve is driving the market bus. Rate cut expectations have been re-drawn, and the “buy everything” sentiment that powere...

AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC's 'Final Trades' | Benzinga

On CNBC’s "Halftime Report Final Trades," Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc. (NASDAQ: GILD) is an inexpensive...
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today | Benzinga

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 5.26% on an annualized basis producing an average annual return...

This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns | Benzinga

BofA Securities downgraded Bristol-Myers Squibb & Co (NYSE: BMY), noting that initially, the analyst believed that Bristol's...

$100 Invested In This Stock 20 Years Ago Would Be Worth $1,100 Today | Benzinga

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 5.22% on an annualized basis producing an average annual return...
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today? | Benzinga

Gilead Sciences Inc (NASDAQ: GILD) announced on Thursday that it has purchased 15 million shares of HOOKIPA Pharma Inc (NASDAQ: HOOK...

RedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against Ebola | Benzinga

RedHill Biopharma Ltd (NASDAQ: RDHL) says opaganib and RHB-107 (upamostat) demonstrated robust synergistic effects when combined individually ...

Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today? | Benzinga

Gilead Sciences Inc (NASDAQ: GILD) announced an agreement with Compugen Ltd (NASDAQ: CGEN) to license its pre-clinical antibody prog...
Previous 10 Next 10